Dynamic Technology Lab’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,560
| Closed | -$2.58M | – | 1424 |
|
|
2025
Q1 | $2.58M | Buy |
+19,560
| New | +$2.44M | 0.37% | 32 |
|
|
2024
Q3 | – | Sell |
-10,947
| Closed | -$750K | – | 1431 |
|
|
2024
Q2 | $750K | Buy |
+10,947
| New | +$759K | 0.08% | 390 |
|
|
2023
Q3 | – | Sell |
-5,020
| Closed | -$318K | – | 1405 |
|
|
2023
Q2 | $318K | Buy |
+5,020
| New | +$313K | 0.04% | 686 |
|
|
2022
Q3 | – | Sell |
-17,910
| Closed | -$1.02M | – | 1602 |
|
|
2022
Q2 | $1.02M | Buy |
17,910
+6,090
| +52% | +$345K | 0.12% | 302 |
|
|
2022
Q1 | $723K | Buy |
+11,820
| New | +$614K | 0.09% | 422 |
|
|
2021
Q4 | – | Sell |
-21,780
| Closed | -$812K | – | 1560 |
|
|
2021
Q3 | $812K | Buy |
+21,780
| New | +$757K | 0.1% | 332 |
|
|
2019
Q4 | – | Sell |
-11,716
| Closed | -$88K | – | 1366 |
|
|
2019
Q3 | $88K | Buy |
+11,716
| New | +$112K | 0.02% | 882 |
|
|
2018
Q3 | – | Sell |
-12,048
| Closed | -$213K | – | 1410 |
|
|
2018
Q2 | $213K | Buy |
12,048
+640
| +6% | +$13K | 0.03% | 825 |
|
|
2018
Q1 | $240K | Sell |
11,408
-6,501
| -36% | -$127K | 0.04% | 815 |
|
|
2017
Q4 | $259K | Buy |
17,909
+2,463
| +16% | +$38K | 0.05% | 771 |
|
|
2017
Q3 | $244K | Buy |
+15,446
| New | +$227K | 0.04% | 828 |
|
|
2017
Q1 | – | Sell |
-15,847
| Closed | -$239K | – | 1318 |
|
|
2016
Q4 | $239K | Buy |
+15,847
| New | +$224K | 0.06% | 640 |
|
Other funds holding ITCI
Dynamic Technology Lab's ITCI Position: Q2 2025 in Review
Dynamic Technology Lab sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 19,560 shares — an estimated $2.58M sold.
Dynamic Technology Lab first reported a position in ITCI in Q4 2016 and held it in 12 quarters. The position peaked at $2.58M in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Dynamic Technology Lab reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Dynamic Technology Lab sold 19,560 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $2.58M.
- Dynamic Technology Lab first reported a position in Intra-Cellular Therapies Inc. in Q4 2016 and held it in 12 quarters.
- Dynamic Technology Lab's Intra-Cellular Therapies Inc. position peaked at $2.58M in Q1 2025.
- 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Dynamic Technology Lab's 13F filing for Q2 2025, filed 12 Aug 2025.